Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$74.61 -1.12 (-1.48%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Market Capitalization (2018 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) posted Market Capitalization of $9.98 billion for Q2 2026, up 143.4% from $4.1 billion a year earlier and up 34.9% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Market Capitalization (2018 - 2026) Analysis & Trends

For FY2025, Kiniksa Pharmaceuticals International's Market Capitalization came in at $6.3 billion, up 119.4% from FY2024.

  • Annual Market Capitalization has increased for four consecutive years, with a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • In prior years, Kiniksa Pharmaceuticals International's Market Capitalization was $2.87 billion in FY2024 (+16.1%), $2.47 billion in FY2023 (+18.5%), $2.09 billion in FY2022 (+28.5%) and $1.63 billion in FY2021 (-32.6%).
  • The Q2 2026 figure stands as the highest quarterly Market Capitalization in data going back to Q2 2018.
  • On a year-over-year basis, Market Capitalization has increased in each of the last 16 quarters, with growth averaging 74.0% over the last eight quarters.
  • The strongest year-over-year quarter for Market Capitalization in the past five years was Q2 2026, with growth of 143.4%; the weakest was Q1 2022, with a decline of 45.6%.
  • According to Business Quant data, Market Capitalization for the three prior quarters was $7.4 billion (Q1 2026), $6.3 billion (Q4 2025) and $5.89 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.98 Bn
Mar 31, 2026 7.40 Bn
Dec 31, 2025 6.30 Bn
Sep 30, 2025 5.89 Bn
Jun 30, 2025 4.10 Bn
Mar 31, 2025 3.24 Bn
Dec 31, 2024 2.87 Bn
Sep 30, 2024 3.61 Bn
Jun 30, 2024 2.66 Bn
Mar 31, 2024 2.71 Bn
Dec 31, 2023 2.47 Bn
Sep 30, 2023 2.44 Bn
Jun 30, 2023 1.98 Bn
Mar 31, 2023 1.50 Bn
Dec 31, 2022 2.09 Bn
Sep 30, 2022 1.79 Bn
Jun 30, 2022 1.35 Bn
Mar 31, 2022 1.38 Bn
Dec 31, 2021 1.63 Bn
Sep 30, 2021 1.57 Bn
API Access

Kiniksa Pharmaceuticals International Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=KNSA&period=max&api_key=YOUR_API_KEY